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Skin epitheliamust rejuvenate constantly during normal homeostasis and repair damage after wounding. Ful-
filling these roles necessitates reservoirs of stem cells that persist for life. This review focuses on the elusive
stem cell niche of the epidermis, long thought to reside within the basal layer that is sandwiched between the
basement membrane and the suprabasal interface.The Epidermal Basal Layer
The skin epidermis serves as the barrier that protects us against
the physical, chemical, and thermal assaults of our environment.
To achieve these feats, the epidermis generates an elaborate
array of supportive appendages, including hair follicles (HFs),
sebaceous glands, sweat glands, and nails.
The existence of stem cells within mammalian epidermis is
illustrated by the ability to maintain and propagate newborn
human (foreskin) epidermal cells in vitro for many generations
(reviewed in Green, 2008). Moreover, after culture, these cells
are still sufficiently resilient to provide long-term regenerative
potential to patients whose skin has been badly burned.
The stem cells of adult epidermis have long been thought to
reside within the innermost (basal) layer of this stratified epithe-
lium, which rests upon a basement membrane (BM) rich in extra-
cellular matrix (ECM) proteins and growth factors (Figure 1).
Common to many stem cell niches, the BM forms a boundary
between epidermis and dermis. Basal cells rely upon mesen-
chymal and BM stimuli to remain proliferative. As they exit this
niche and move to suprabasal locations, basal cells terminally
differentiate via a spinous cell intermediate, culminating in dead
enucleated cells that provide the epidermal barrier until they are
shed and replaced by inner layer cells moving outward (reviewed
in Blanpain and Fuchs, 2009). The direction of movement is
largely columnar, as predicted by Potten many years ago, and
supported by mosaic keratin-promoter-driven transgenic mice.
Much of the action takes place at the basal-to-spinous cell inter-
face, where basal cells receive microenvironmental cues that
influence when to proliferate, differentiate, or function in wound
repair. The extent to which individual basal cells experience envi-
ronmental heterogeneity and whether such variety in external
cues impacts epidermal stem cell number remain unclear.
Regulation of the Basal-to-Suprabasal Switch
Recognized decades ago, the switch between expression of
cytoskeletal keratins K5/K14 and K1/K10 is a reliable indicator
that an epidermal cell has left its basal niche and committed to
terminally differentiate (Blanpain and Fuchs, 2009). One of the
main signals orchestrating the basal-to-suprabasal switch is
Notch: ligands for Notch reside in the basal layer, and receptors
for Notch are expressed suprabasally by spinous cells. Too
much Notch activity promotes the fate of K1/K10-expressing
spinous cells, while too little results in a diminution of this differ-
entiated state (Blanpain and Fuchs, 2009).One of Notch’s classical target genes encodes the transcrip-
tional repressor Hes1, shown recently to maintain spinous cell
fate in the developing embryo (Moriyama et al., 2008). In addi-
tion, Notch signaling induces C/EBPs, which transcriptionally
regulate many differentiation-specific genes, including K1 and
K10. To fully activate this program, AP2 transcription family
factors collaborate with Notch (Wang et al., 2008; Figure 1).
Epidermis expresses AP2a (basal preferred) and AP2g (supra-
basal preferred), and most of its genes possess AP2 transcrip-
tion-factor-binding sites in their 50 regulatory regions (Blanpain
and Fuchs, 2009). When singly targeted, epidermal development
and homeostasis are only mildly perturbed, but double targeting
of AP2a/g abrogates C/EBP expression, crippling differentiation
(Wang et al., 2008). AP2a promotes spinous cell commitment by
tempering epidermal growth factor receptor (EGFR) signaling,
a molecular advocate of growth and a repressor of Notch signal-
ing (Kolev et al., 2008).
Further insights into the switch mechanism emanate from
studies on p63. In the late 1990s, two groups studying the p53
family of proto-oncogenes independently discovered that mice
mutant for p63 are severely compromised in skin development
(Koster et al., 2004 and references therein). Uncommitted ecto-
dermal cells covered most of the body surface of p63 mutants,
but a few clumps of differentiated epidermal cells remained.
This phenotype may reflect an absence of lineage commitment
and an early block in epidermal differentiation, or a secondary
defect in epithelial stem-cell renewal and/or survival. Discerning
between these options is challenging because the p63 gene
encodes TAp63 and DNp63 isoforms, which arise from differen-
tial promoter usage, as well as a, b, and g subtypes.
DNp63a is the most highly expressed and conserved p63 iso-
form in stratified epithelia, where it is seen mainly in the basal
layer (Koster et al., 2004). DNp63a lacks the transactivation
domain present in p53 but shares its DNA and tetramerization
domains. Using an in vitro model of human epidermal regenera-
tion, Truong and Khavari tested whether the isoform functions as
a dominant-negative p53 antagonist (Truong and Khavari, 2007).
They observed that reducing p63 mRNA levels reduced cell
proliferation, and when p53 and p63 small interfering RNAs
(siRNAs) were added together, normal cell proliferation was
restored. While this study accentuates the opposing effects of
DNp63a and p53 on cell growth, loss of p63 can also increase
apoptosis (Senoo et al., 2007). Thus, it is still unclear whether the
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p53 or via disruption of stress-induced, p53-dependent apoptosis.
Interestingly, p53 siRNA did not rescue terminal differentiation
in vitro (Truong and Khavari, 2007), suggesting that p63 governs
human epidermal differentiation independent of its role in cell
proliferation/survival. These results further highlight the potential
significance of p63 isoforms such as DNp63a that possess
a protein-protein interacting domain not present in p53. It is
tempting to speculate that, during homeostasis, DNp63a
represses key genes and maintains basal cells in their undiffer-
entiated progenitor state. On the other hand, DNp63a might
endow basal progenitors with the ability to differentiate (Koster
et al., 2004). Elucidating DNp63a’s interaction partners should
shed important new insights into its function(s).
In addition, the 30UTR of mouse DNp63a mRNA possesses
seed sequences for miR-203, a microRNA expressed in all
transcriptionally active, terminally differentiating skin epithelial
cells, but not in proliferative compartments (Yi et al., 2008;
Figure 1). ConsistentwithmicroRNAs as translational repressors,
DNp63a and miR-203 display mirror image expression patterns.
Importantly, gain- and loss-of-function studies in mice support
the view thatmiR-203 acts at least in part by negatively regulating
suprabasal expression of basal genes, thereby refining the basal/
spinous boundary and the switch between proliferation and
differentiation (Yi et al., 2008). In this regard, Notch signaling
not only activates spinous fate, but also represses basal fate
through reducing p63 and integrin levels. These effects on basal
fate are complex and not always mediated through canonical
mechanisms (Blanpain and Fuchs, 2009; Moriyama et al.,
2008). An intriguing question iswhetherNotch signaling activates
miR-203 gene expression, further repressing basal fate and seal-
ing commitment in newly suprabasal cells.
The basal-to-spinous switch is also fine-tuned by epigenetic
modifications. For example, Frye and Watt observed that b1
Figure 1. The Architecture of the Basal-to-Spinous Switch
The proliferative basal cells of the epidermis adhere to an underlying basement
membrane, separating the dermis from the epidermis, and differentiate into
spinous cells in the suprabasal layer. Integral to this switch are epigenetic
changes in chromatin and Notch signaling, which are activated in spinous
cells. Notch is thought to be repressed in basal cells by several mechanisms,
including the Notch inhibitor Numb, which is frequently asymmetrically in-
herited after basal cell division. In turn, Notch signaling downregulates integrin
and p63 gene expression and, in conjunction with AP2s, activates C/EBP
expression. Models of how asymmetric divisions could promote the basal-
to-spinous switch are depicted. Epidermal drawing by Ann Canapary.500 Cell Stem Cell 4, June 5, 2009 ª2009 Elsevier Inc.integrin-enriched cells are associated with reduced levels of
histone H4 acetylation (Frye et al., 2007). This pattern also holds
for mouse interfollicular epidermis (IFE) and for HF, suggesting
antagonistic roles for H4 acetylation and basal cell behavior.
Histone acetylation is associated with active gene expression
in general and with c-Myc in particular. In earlier studies, Watt
and colleagues suggested a role for c-Myc in driving stem cells
to a transient amplifying state en route to differentiation and
found that elevated c-Myc expression in basal cells led to wide-
spread enhancement of H4 acetylation as well as additional H4
modifications at lysine 20. These data have led to the view that
activated c-Myc may promote a chromatin state permissive for
epidermal differentiation (Frye et al., 2007).
In addition, Sen and Khavari globally mapped chromatin from
cultured human epidermal keratinocytes for enrichment of the
negative histone mark H3K27me3 (Sen et al., 2008). Under
growth-promoting conditions, 10% of the gene promoters
assayed were enriched for H3K27me3. Conversely, in differentia-
tionconditions, thepromotersof nearly 10%ofgenesupregulated
in keratinocytes had reduced H3K27me3-marked chromatin. The
possible functional significance of this opposing correlation in
histone modification was underscored by siRNA targeting of
JMJD3, the demethylase thought to be responsible for removing
the H3K27me3 mark. In human organotypic cultures, reductions
in the demethylase correlated with repression of epidermal differ-
entiation, while overexpression of JMJD3 enhanced differentia-
tion (Sen et al., 2008).
These studies are particularly interesting in light of our own
recent finding that Ezh2, the H3K27me3 methylase at the core
of polycomb complex group (PcG)-mediated chromatin repres-
sion, functions in the basal layer of mouse embryonic epidermis
in vivo to repress a bank of genes involved in epidermal terminal
differentiation (Ezhkova et al., 2009). While the full molecular
mechanisms remain uncharacterized, many of these promoters
possess binding sites for AP1 transcription factors known to
be involved in epidermal differentiation (Zenz and Wagner,
2006). Notably, some AP1 members are expressed basally,
albeit at reduced levels compared to suprabasally, and the nega-
tive H3K27me3 histone blocked accessibility of AP1 factors to
the marked genes in basal cells (Ezhkova et al., 2009).
This regulatory pattern is acutely relevant, in that many genes
involved in nonepidermal differentiation programs are also gov-
erned by PcG repression in developing epidermis, and they too
lose their H3K27me3 mark when Ezh2 is lost (Ezhkova et al.,
2009). In contrast to PcG-regulated epidermal genes, however,
muscle and neuronal genes remain repressed and don’t bind
AP1 factors in Ezh2-depleted basal epidermal cells. Presumably,
nonepidermal gene expression depends upon other tissue-
specific transcription factors not present in the basal cell popu-
lation.
Interestingly, loss of Ezh2 (Ezhkova et al., 2009) and JMJD3
(Sen et al., 2008) were both accompanied by precocious
epidermal maturation/accelerated differentiation suprabasally,
rather than premature differentiation of basal cells. It is tempting
to speculate that full-throttle differentiation is dependent upon
induction of additional transcription factors, including C/EBPs,
which are induced in response to regionally dependent environ-
mental cues, e.g., Notch signaling. Alternatively, it may be that
the phenotypes observed to date have not revealed the impact
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and Ezh1 could partially compensate for Ezh2. Other chromatin
modifications, including histone deacetylation, may also be
involved (Frye et al., 2007).
It is also interesting that epidermal differentiation genes are
repressed by PcG in embryonic stem cells (ESCs), which are
poised to activate more tissue-specific differentiation programs
than their epidermal counterparts (Chi and Bernstein, 2009).
ESCs appear to maintain this pliability by marking critical differ-
entiation genes not only with PcG repressive marks but also with
an active histone 3 mark, lysine 4 (Chi and Bernstein, 2009). This
double marking could explain why loss of PcG repression in
ESCs results in activation of many differentiation pathways (Chi
and Bernstein, 2009). In contrast, PcG-marked epidermal differ-
entiation genes do not display this active mark in embryonic
basal cells (Ezhkova et al., 2009). Rather, epidermal stem cells
appear to couple PcG repression with a requirement for tissue-
specific transcriptional activators, thereby leading to selective
lineage induction only when environmentally cued.
Lift-Off from the BM Launchpad
In addition to signaling cues that are delivered across the basal-
spinous interface, the basal layer also receives regulatory input
from ‘‘below.’’ Although mechanophysical properties alone are
likely to influence the proliferative properties of basal cells, the
BM also provides a diverse repertoire of proliferative stimuli for
basal cells. Among them is laminin 5, which promotes
anchorage, signaling, and migration by acting as ligand for
a6b4 at the core of hemidesmosomes and a3b1 integral to focal
adhesions (FAs) (Blanpain and Fuchs, 2009; Owens and Watt,
2003). Cultured human epidermal cells that exhibit higher levels
of b1 integrin have greater proliferative potential in vitro than
other cells within the population (Owens and Watt, 2003). Upon
a3b1 integrin activation, a kinase cascade including focal adhe-
sion tyrosine kinase (FAK) and Src tyrosine kinase is unleashed,
not only stimulating the Ras-MAPK pathway, but also inducing
focal adhesion turnover and epidermal migration (Guasch
et al., 2007).
Balancing attachment, detachment, and migration is crucial
for the basal epidermal cell. Notably, transgenic suprabasal
expression of integrins promotes tumorigenesis in mice (Owens
and Watt, 2003). Conversely, conditional loss of FAK leads to an
increased resistance to chemically induced skin tumorigenesis,
and in vitro, FAK-deficient keratinocytes exhibit defects in cell
migration and focal adhesion turnover (Guasch et al., 2007 and
references therein).
The BM is also rich in proteoglycans and other proteins, which
cast a molecular net for growth-regulatory factors. TGFbs
restrict epidermal proliferation, and TGFa, EGFs, and insulin
growth factors enhance proliferation (Zenz and Wagner, 2006).
When TGFb receptor signaling is compromised, epidermal
homeostasis is maintained, but the apparent normalcy is decep-
tive (Guasch et al., 2007). In this setting, wounds heal faster,
basal cells display increased proliferation counterbalanced by
increased apoptosis, and with just one additional oncogenic
mutation, the tissue transforms quickly to squamous cell carci-
noma of the skin.
The opposing effects of FAK/integrin and TGFb signaling on
basal cell behavior are intertwined. Elevating integrin signalingsuppresses TGFb signaling (Owens and Watt, 2003), and
conversely when TGFb signaling in epidermis is compromised,
FAK/integrins are activated and migration is enhanced (Guasch
et al., 2007). EGF receptor (EGFR) signaling aligns with activated
FAK/integrins in eliciting these responses (Zenz and Wagner,
2006). In addition, the underlying dermis is known to undergo
significant crosstalk with the epidermal basal layer in orches-
trating its proliferative and migratory behaviors (Blanpain and
Fuchs, 2009; Zenz and Wagner, 2006).
How do these signaling pathways participate to preserve
stemness? While the underlying mechanisms are still elusive,
epidermal basal cells rely heavily upon these regulatory circuits.
Mitogen-inducible gene 6 is a suppressor of EGFR signaling, and
mice deficient in mitogen-inducible gene 6 display epidermal hy-
perproliferation and increased tumor susceptibility (Ferby et al.,
2006). Another inhibitor of EGFR signaling, Lrig1, is expressed
throughout the basal layer of human epidermis but seems to
be enriched within less proliferative, b1 integrin-enriched cells
(Jensen et al., 2009 and references therein). Mice lacking Lrig1
display a hyperproliferative epidermis, and human keratinocytes
faced with an Lrig1 short hairpin RNA produce larger colonies
than normal. These observations led Jensen and Watt to posit
that Lrig1 might regulate slow cycling features of basal stem
cells. When taken together with the AP2a-EGFR-Notch circuitry
discussed above, these studies underscore a key role for the
EGFR signaling pathway in controlling basal fate and for Notch
in regulating suprabasal fate.
As the regulatory roles for additional BM constituents and their
associates continue to unfold, the extrinsic signals received by
the microenvironment and translated through transmembrane
receptors are expected to couple with the intrinsic properties
of the basal epidermal cells to define their ability to self-renew
and undergo homeostasis and wound repair.
Superimposed on these regulatory pathways is the contribu-
tion of the BM and integrins to establish the polarity that enables
basal epidermal cells to orient their spindle and divide properly.
During embryonic development, divisions occur in a plane
parallel to the BM in the single-layered epidermis. Upon stratifi-
cation, a majority of divisions become asymmetrically oriented,
relative to the BM (Lechler and Fuchs, 2005). While this orienta-
tion is maintained during development, in adult, asymmetric divi-
sions that leave both daughter cells attached to the BM can
occur (Clayton et al., 2007). Specific orientation appears to rely
upon asymmetric polarity cues that lead one spindle pole and
its astral microtubules to associate with the cortical actin cyto-
skeleton (Figure 1). Notably, without b1 integrin or a-catenin,
spindle orientation becomes randomized (Lechler and Fuchs,
2005).
Several models can explain how the alignment of asymmetric
divisions might produce one basal progenitor and one
committed cell (Figure 1). If asymmetric to the BM, a division
would automatically place one daughter in the suprabasal layer.
If parallel, one daughter might inherit factors to reduce the level
of integrins, thereby leading to an early departure from the BM
niche. In this regard, it is interesting that asymmetric divisions
frequently involve asymmetric inheritance of a stronger Notch
signal, and in the epidermis, elevated Notch signaling basally
results in decreased integrin gene expression (reviewed by Blan-
pain and Fuchs, 2009).Cell Stem Cell 4, June 5, 2009 ª2009 Elsevier Inc. 501
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One of the last frontiers in epidermal biology is the location of its
stem cells, and if this is within the basal layer, to what extent the
heterogeneity exhibited by basal epidermal cells reflects a differ-
ence in their ability to self-renew long-term and generate
epidermis. Humans have a thick epidermis with frequent
epidermal turnover in vivo and a propensity to yield long-term
epidermal cultures in vitro. By contrast, while the mouse is
genetically tractable and therefore perfect for addressing the
issue, it displays a thinner, less active epidermis, whose cells
are difficult to culture long-term.
Recently, a population of murine HF stem cells was identified
that is enriched for Lrig1 and Blimp1, and that gives rise to IFE
and SGs when stimulated by retinoic acid in vivo (Jensen et al.,
2009 and references therein). It has been suggested that these
cells might be the elusive IFE stem cells. However, three different
lineage tracing studies with Cre recombinase driven by either
Shh, Sox9, or cytochrome P450 promoters each document
that mouse IFE harbors its own resident progenitors, which
can sustain epidermal homeostasis long-term (Levy et al.,
2007; Jones et al., 2007; Nowak et al., 2008). Moreover, even
though efficient wound repair in mice draws heavily from follicle
cells, epidermal cells do contribute, as exemplified by the Edar-
add mutant mouse, whose tail skin lacks HFs but is nevertheless
able to slowly repair its wounds (Langton et al., 2008).
Upon severe injury, IFE can even regenerate HFs, leading to
the view that epidermal basal cells not only self-renew long-
term, but are also multipotent (Ito et al., 2007). These findings
also raise the possibility that some properties might be shared
between epidermal and HF stem cells; however, identifying
commonalities has been challenging. A few adult basal cells
do show preferential label retention, but they lack defined spatial
distribution and aren’t easily traced to embryonic skin (Nowak
et al., 2008). Moreover, only a few molecular parallels between
HF bulge stem cells and IFE basal cells have been defined,
and most, such as K5, K14, and p63, mark all skin epithelial cells
with proliferative capacity, whether stem cells or not. The paucity
of specific stem cell markers, coupled with their relatively weak
display of self-renewal, suggests that either the number or
long-term potential of mouse epidermal stem cells within the
basal layer is small.
Lineage tracing of single basal cells in tail skin, where mitoses
are more frequent than in back skin, suggests that, while the
majority of labeled cells are lost within 3 months, some survive
and clonally expand in size over time (Clayton et al., 2007). This
behavior seems to argue against long-standing models of
a discrete epidermal proliferating unit composed of one stem cell
surrounded by a steady-state pool of 10 transit-amplifying
progeny that subsequently exit the niche and terminally differen-
tiate (Clayton et al., 2007). Rather, mathematical modeling of the
long-term fate of marked basal cells suggests that they could all
be equivalent (Clayton et al., 2007). That said, interpretation is
confounded on the one hand by environmental assaults that could
elicit localized epidermal wound repair, and on the other, by the
possibility that longer-termstemcellsmight escapebeingmarked.
In the future, it will be important to determine whether there is
a hierarchy in the relative abilities of individual cells within the
basal epidermal layer versus the HF to self-renew and generate
epidermal tissue long-term. For now, resolution as to whether502 Cell Stem Cell 4, June 5, 2009 ª2009 Elsevier Inc.basal cells are equivalent and how basal progenitors relate to
their better-characterized cousins in the HF awaits identification
of the genes that mediate the long-term, self-renewing capacity
of the epidermis. Therein lie the clues to the identity of the IFE
stem cell and its niche.
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